HEIDENREICH PA， BOZKURT B， AGUILAR D， et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure： executive summary：a report of the American college of cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. Circulation，2022，145（18）：876-894.

胡盛寿， 王增武. 《中国心血管健康与疾病报告2022》概述[J].中国心血管病研究，2023，21（7）：577-600.

MARTYNIAK A，TOMASIK PJ. A new perspective on the renin-angiotensin system[J]. Diagnostics （Basel），2022，13（1）：123-128.

ONG SB，HERNÁNDEZ-RESÉNDIZ S，CRESPO-AVILAN GE，et al. Inflammation following acute myocardial infarction： Multiple players， dynamic roles， and novel therapeutic opportunities[J]. Pharmacol Ther，2018，186：73-87.

TILEA I， VARGA A， SERBAN RC. Past， present， and future of blood biomarkers for the diagnosis of acute myocardial infarction-promises and challenges[J]. Diagnostics （Basel），2021，11（5）：23-34.

GHAFOURI-FARD S， KHANBABAPOUR SASI A， HUSSEN BM， et al. Interplay between PI3K/AKT pathway and heart disorders[J]. Mol Biol Rep，2022，49（10）：9767-9781.

SAMAKOVA A， GAZOVA A， SABOVA N， et al. The PI3k/Akt pathway is associated with angiogenesis， oxidative stress and survival of mesenchymal stem cells in pathophysiologic condition in ischemia[J]. Physiol Res，2019，68（Suppl 2）：131-138.

QIN W, CAO L, MASSEY IY. Role of PI3K/Akt signaling pathway in cardiac fibrosis[J]. Mol Cell Biochem, 2021,476(11):4045-4059.

FRUMAN DA, CHIU H, HOPKINS BD, et al. The PI3K pathway in human disease[J]. Cell,2017,170(4):605-635.

YANG J，NIE J，MA X，et al. Targeting PI3K in cancer：mechanisms and advances in clinical trials[J]. Mol Cancer，2019，18（1）：26.

HERS I， VINCENT EE， TAVARÉ JM. Akt signalling in health and disease[J]. Cell Signal，2011，23（10）：1515-1527.

HUA H， ZHANG H， CHEN J， et al. Targeting Akt in cancer for precision therapy[J]. J Hematol Oncol，2021，14（1）：128.

XIA P， XU XY. PI3K/Akt/mTOR signaling pathway in cancer stem cells： from basic research to clinical application[J]. Am J Cancer Res，2015，5（5）：1602-1609.

POMPURA SL，DOMINGUEZ-VILLAR M. The PI3K/AKT signaling pathway in regulatory T-cell development， stability， and function[J]. J Leukoc Biol，2018，79（6）：1019-1031.

NATHAN N， KEPPLER-NOREUIL KM， BIESECKER LG， et al. Mosaic disorders of the PI3K/PTEN/AKT/TSC/mTORC1 signaling pathway[J]. Dermatol Clin, 2017,35（1）：51-60.

ZHANG M， ZHANG X. The role of PI3K/AKT/FOXO signaling in psoriasis[J]. Arch Dermatol Res，2019，311（2）：83-91.

AIMO A， CASTIGLIONE V， BORRELLI C， et al. Oxidative stress and inflammation in the evolution of heart failure： from pathophysiology to therapeutic strategies[J]. Eur J Prev Cardiol，2020，27（5）：494-510.

SONGBO M， LANG H， XINYONG C， et al. Oxidative stress injury in doxorubicin-induced cardiotoxicity[J]. Toxicol Lett，2019，307：41-48.

JAIN AK， MEHRA NK， SWARNAKAR NK. Role of antioxidants for the treatment of cardiovascular diseases： challenges and opportunities[J]. Curr Pharm Des，2015，21（30）：4441-4455.

ORNELLAS FM， ORNELLAS DS， MARTINI SV， et al.Bone marrow-derived mononuclear cell therapy accelerates renal ischemia-reperfusion injury recovery by modulating inflammatory， antioxidant and apoptotic related molecules[J]. Cell Physiol Biochem，2017，41（5）：1736-1752.

LIAO L， GONG L， ZHOU M， et al. Leonurine ameliorates oxidative stress and insufficient angiogenesis by regulating the PI3K/Akt-eNOS signaling pathway in H2O2-induced HUVECs[J]. Oxid Med Cell Longev，2021：9919466.

KU HC， LEE SY， YANG KC， et al. Modification of caffeic acid with pyrrolidine enhances antioxidant ability by activating AKT/HO-1 pathway in heart[J]. PLoS One，2016，11（2）：e0148545.

ZHANG Q， LIU J， DUAN H， et al. Activation of Nrf2/HO-1 signaling： An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress[J]. J Adv Res，2021,34:43-63.

刘雪岩， 李成花， 杨萍.炎症反应在心梗后心衰发病过程中的作用研究进展[J]. 分子影像学杂志，2017，40（1）：81-84.

FRANGOGIANNIS NG.The inflammatory response in myocardial injury， repair， and remodelling[J]. Nat Rev Cardiol，2014，11（5）：255-265.

朱志扬， 葛然， 杨露露. 人参皂苷Rb1通过抑制PI3K/AKT信号通路保护脂多糖诱导的心肌细胞炎症反应[J]. 中国循证心血管医学杂志，2018，10（7）：823-826.

LI D, GUO YY, CEN XF, et al. Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways[J]. Acta Pharmacol Sin, 2022,43(8):1989-2002.

陈浥尘， 陈广洁， 陈红. M1/M2型巨噬细胞与心血管疾病关系的研究进展[J].现代免疫学，2015，35（6）：507-510.

VERGADI E, IERONYMAKI E, LYRONI K, et al. Akt signaling pathway in macrophage activation and M1/M2 polarization[J]. J Immunol, 2017,198(3):1006-1014.

YIN J, HU L, HAN X, et al. MiR-18a-5p aggravates homocysteine-induced myocardial injury via autophagy[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023,48(1):24-33.

BEROSKE L，VAN DEN WYNGAERT T，STROOBANTS S， et al. Molecular imaging of apoptosis： the case of caspase-3 radiotracers[J]. Int J Mol Sci，2021，22（8）：88-99.

PAHLAVANI HA. Exercise-induced signaling pathways to counteracting cardiac apoptotic processes[J]. Front Cell Dev Biol，2022，10：950927.

CHEN X, ZHANG H, FENG M, et al. A novel peptide HSP-17 ameliorates oxidative stress injury and apoptosis in H9c2 cardiomyocytes by activating the PI3K/Akt pathway[J]. Ann Transl Med, 2022,10(24):1357.

MCLOUGHLIN NM, MUELLER C, GROSSMANN TN. The therapeutic potential of PTEN modulation: targeting strategies from gene to protein[J]. Cell Chem Biol, 2018,25(1):19-29.

WEN Z, MAI Z, ZHU X, et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway[J]. Stem Cell Res Ther, 2020,11(1):36.

LU JM, ZHANG ZZ, MA X, et al. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy[J]. Exp Eye Res, 2020,190:107886.

CHENG Y, JIANG S, HU R, et al. Potential mechanism for endothelial progenitor cell therapy in acute myocardial infarction: Activation of VEGF- PI3K/Akte-NOS pathway[J]. Ann Clin Lab Sci, 2013,43(4):395-401.

耿军辉, 张丽军, 王亚丽,等. PI3K/Akt信号通路与肿瘤血管新生的研究进展[J]. 现代肿瘤医学,2018,26(9):1462-1466.

程嵩奕.黄芪甲苷调控PTEN/PI3K/Akt信号通路介导心肌梗死后血管新生与心肌保护的实验研究[D].南京：南京中医药大学，2018.

JING R, ZHONG QQ, LONG TY, et al. Downregulated miRNA-26a-5p induces the apoptosis of endothelial cells in coronary heart disease by inhibiting PI3K/AKT pathway[J]. Eur Rev Med Pharmacol Sci, 2019,23(11):4940-4947.

李军， 张振鹏， 熊兴江，等.稳心汤治疗不稳定性心绞痛的随机对照研究[J].中国实验方剂学杂志，2016，22（4）：154-158.

张丞波, 张苏洁, 杨月东,等. 益气活血方对急性ST段抬高型心肌梗死后心力衰竭患者心肌纤维化的影响[J]. 南京中医药大学学报,2023,39(2):111-117.

何贵新, 肖婷, 秦伟彬,等. 基于PI3K/AKT信号通路探讨芪参益气滴丸改善心肌缺血再灌注损伤的实验研究[J]. 北京中医药大学学报,2020,43(9):762-768.

ZHANG J, CUI Q, ZHAO Y, et al. Mechanism of angiogenesis promotion with Shexiang Baoxin Pills by regulating function and signaling pathway of endothelial cells through macrophages[J]. Atherosclerosis, 2020,292:99-111.

ZHANG B, MA Q, MA FZ, et al. Astragaloside Ⅳ's therapeutic effect on myocardial infarction via affecting autophagy and the mechanism study[J]. Sichuan Da Xue Xue Bao Yi Xue Ban, 2021,52(2):222-228.

LIU H, LIU W, QIU H, et al. Salvianolic acid B protects against myocardial ischaemia-reperfusion injury in rats via inhibiting high mobility group box 1 protein expression through the PI3K/Akt signalling pathway[J]. Naunyn Schmiedebergs Arch Pharmacol, 2020,393(8):1527-1539.

CHEN X, XIE Q, ZHU Y, et al. Cardio-protective effect of tetrahydrocurcumin, the primary hydrogenated metabolite of curcumin in vivo and in vitro: Induction of apoptosis and autophagy via PI3K/AKT/mTOR pathways[J]. Eur J Pharmacol, 2021,911:174495.